Clinical Trials on Urinary Tract Infections, Recurrent

Total 73737 results

University of Wisconsin, Madison

Completed

Rigid Versus Flexible Cystoscopy in Women

Urination Disorders | Hematuria | Recurrent Urinary Tract Infection | Voiding Dysfunction

United States
V.K.V. American Hospital, Istanbul

Completed

Low Molecular Weight Heparin in Recurrent Implantation Failure

Infertility | Recurrent Implantation Failure | Fertilization in Vitro

Turkey
Rebiotix Inc.

Completed

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD2)

Enterocolitis Clostridium Difficile Recurrent

United States, Canada
David M Lubaroff
United States Department of Defense

Completed

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

Recurrent Prostate Cancer

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection

Staphylococcal Aureus Infection | Recurrent Staphylococcal Infection | Invasive Staphylococcal Infection

United States
Peking University Third Hospital

Unknown

Effect of Reproductive Tract Microbiota on Pregnancy Outcome in IVF/ICSI

Infertility | Recurrent Miscarriage | Recurrent Implantation Failure

China
Precigen, Inc
National Cancer Institute (NCI)

Active, not recruiting

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Papillomavirus Infections | Recurrent Respiratory Papillomatosis | Papillomaviridae

United States
Assiut University

Unknown

Histopathological Evaluation of Product of Conception in Sporadic and Recurrent Abortions

Recurrent Abortion
Benha University

Completed

Sildenafil Citrate and Recurrent Abortion

Recurrent Abortion
Ain Shams University

Completed

Iron Supplementation Outcome on Recurrent Upper Respiratory Tract Infections in 6-15 Years Old Egyptian School Children

Iron Deficiency Anemia | Recurrent Upper Respiratory Tract Infections

Egypt
Unity Health Toronto
Applied Health Research Centre

Active, not recruiting

Phage Therapy for the Treatment of Urinary Tract Infection

Recurrent Urinary Tract Infection

Canada
National Nutrition and Food Technology Institute

Completed

Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion

Recurrent Abortion
University of Louisville

Completed

Vaginal and Urinary Microbiome Trial

Menopause | Atrophic Vaginitis | Recurrent Urinary Tract Infections

United States
Imagine Institute

Recruiting

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ") (REPA)

Juvenile Recurrent Respiratory Papillomatosis

France
Menoufia University

Completed

Platelet Indices and Recurrent Pregnancy Loss

Abortion, Recurrent

Egypt
Ain Shams University

Completed

Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss

Miscarriage, Recurrent

Egypt
Omar Mamdouh Shaaban

Completed

Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies (LMWH-APAN)

Recurrent Miscarriage
Abbott Products

Completed

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

Recurrent Miscarriage

Austria, Poland
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Recurrent Genital Herpes
University of Washington
National Cancer Institute (NCI); United States Department of Defense

Recruiting

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
University of Washington
National Cancer Institute (NCI); Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
GOG Foundation
National Cancer Institute (NCI)

Completed

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Assiut University

Not yet recruiting

The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage

Recurrent Miscarriage
Japan Blood Products Organization

Completed

A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage

Recurrent Miscarriage

Japan
Rania Hassan Mostafa

Completed

Use of Platelet Indices for Prediction of Recurrent Miscarriage

Recurrent Miscarriage

Egypt
Ahmed Mohamed Bahaa Eldin Ahmed
Ain Shams Maternity Hospital

Unknown

Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion

Recurrent Miscarriage
Assiut University

Completed

Expression of EPK in Recurrent Miscarriage (EPK-RM)

Recurrent Miscarriage

Egypt
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Recurrent Genital Herpes
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...

Completed

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Universiti Kebangsaan Malaysia Medical Centre

Completed

Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure

Miscarriage, Recurrent

Malaysia
Ain Shams University

Unknown

Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages

Recurrent Miscarriage

Egypt
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Benha University

Active, not recruiting

Recurrent Salivary Gland Infections in Covid-19 (RecSalivary)

Recurrent Salivary Gland Infections in Covid-19

Egypt
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (REVERT)

Recurrent Hepatitis C

Argentina
National Cancer Institute (NCI)

Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Pathologic Processes | Infections | Neoplasms | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Neoplasms by Histologic Type | Neoplasms, Glandular and Epithelial | Recurrence | Disease Attributes | Papilloma | DNA Virus Infections | Papillomavirus Infections | Tumor Virus Infections | Neoplasms...

United States
National Cancer Institute (NCI)

Completed

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Sarcoma

United States
Indiana University
Lupin Pharmaceuticals, Inc.

Completed

Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study

Recurrent Bacterial Vaginosis

United States
Nora Therapeutics, Inc.

Unknown

A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) (RESPONSE)

Recurrent Miscarriage | Recurrent Pregnancy Loss

United Kingdom
Murdoch Childrens Research Institute
Royal Children's Hospital

Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Primary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2

Australia, New Zealand
University of Birmingham
Tommy's

Completed

The Role of Hydrosalpinx in Recurrent Miscarriage

Miscarriage, Recurrent | Abortion, Spontaneous | Hydrosalpinx

United Kingdom

Clinical Trials on Urinary Tract Infections, Recurrent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations